The NCLT Allahabad has sanctioned India Glycols’ demerger scheme for its biopharma and spirits businesses under Sections 230–232 after confirming statutory compliances were met.
NCLT Allahabad Approves India Glycols’ Demerger of Biopharma and Spirits Units
The National Company Law Tribunal (NCLT) Allahabad has officially sanctioned the demerger of India Glycols’ biopharma and spirits businesses. This decision was made under Sections 230–232 of the Companies Act, 2013, after the tribunal verified that all statutory compliances were adequately addressed.
The ruling reflects the tribunal’s assessment that the demerger is in the interests of the company and its stakeholders, allowing for specialized management of the distinct business sectors. By facilitating this demerger, the tribunal aims to enhance operational efficiency and shareholder value.
This decision serves as an example for other companies considering demergers, highlighting the importance of meeting regulatory requirements. Practitioners advising clients on corporate restructuring should take note of the procedural standards exemplified in this case.
Citations
- NCLT Allahabad (2026) NCLT Judgments
